@inbook{0e5f1b4a4bca49228ad5c50677d5f9c9,
title = "Overview of Inpatient Management of Diabetes and COVID-19",
abstract = "Diabetes has been identified as a risk factor for inpatient admission in persons with novel coronavirus 2019 (COVID-19). Managing patients with diabetes and COVID-19 is complicated by the use of steroid therapy as well as the immense inflammatory response seen in persons with COVID-19. Insulin management has been found to be the most effective therapy due to its ability for dose adjustment and anti-inflammatory properties. Studies using non-insulin therapies in the inpatient setting have been limited by small sample sizes. This chapter provides an overview of the inpatient care of those with diabetes and COVID-19.",
keywords = "COVID-19, Inpatient diabetes, Insulin, Steroid-induced hyperglycemia",
author = "Fuad Benyaminov and Patricia Garnica and Myers, {Alyson K.}",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.",
year = "2023",
doi = "10.1007/978-3-031-28536-3_8",
language = "English (US)",
series = "Contemporary Endocrinology",
publisher = "Humana Press Inc.",
pages = "111--122",
booktitle = "Contemporary Endocrinology",
}
